eXoZymes, Inc. (EXOZ) News
Follow eXoZymes, Inc. (EXOZ) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
eXoZymes selects Curia as commercial-scale manufacturing partner for NCT
eXoZymes (NASDAQ:EXOZ) said it entered into an agreement with Curia Global as its commercial-scale manufacturing partner for NCT.
EQUITY | Sep 08, 2026, 02:21 PM UTC
L
eXoZymes (EXOZ) selects Curia as commercial-scale manufacturing partner for NCT
EXOZ/eXoZymes selected Curia as a commercial-scale manufacturing partner for NCT.
EQUITY | Sep 08, 2026, 02:20 PM UTC
L
EXOZ/eXoZymes reports Q2 2026 results; business update at 5PM ET
eXoZymes (EXOZ) reports second quarter 2026 results and provides a business update scheduled for 5PM ET today; no figures or catalyst were included in the alert.
EARNINGS | Aug 20, 2026, 08:10 PM UTC
L
EXOZ eXoZymes NCT process delivers 10-fold productivity gain
EXOZ (eXoZymes) says its NCT process achieves a 10-fold productivity increase and advances beyond its original commercial-scale economic targets.
EQUITY | Aug 18, 2026, 08:30 PM UTC
L
EXOZ Schedules Q2 Update Call
EXOZ schedules Q2 update conference call for August 20, 2026
EQUITY | Aug 11, 2026, 08:10 PM UTC
M
EXOZ Awarded $2M Grant
eXoZymes receives $2 million NIH grant to advance cannabinoid analogs for drug discovery
EQUITY | Jun 24, 2026, 08:10 PM UTC